Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis
Author:
Publisher
Informa UK Limited
Subject
Neurology (clinical),Neurology
Link
https://www.tandfonline.com/doi/pdf/10.1080/21678421.2017.1364269
Reference16 articles.
1. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia
2. Inhibitory Effect of MCI-186, a Free Radical Scavenger, on Cerebral Ischemia Following Rat Middle Cerebral Artery Occlusion
3. Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Welche Therapieansätze gibt es bei der amyotrophen Lateralsklerose?;InFo Neurologie + Psychiatrie;2024-05
2. Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis;Expert Review of Neurotherapeutics;2023-09-12
3. The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis;Muscle & Nerve;2023-07-31
4. An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study;JMIR Research Protocols;2023-01-30
5. Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis;Clinical Drug Investigation;2022-12-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3